spacer
home > pmps > summer 2019 > a cold case
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

A Cold Case

Patient safety will always be the top priority of every clinical trial. Therefore, it is vital that the investigational medicine dispensed to the patient is pure, safe, and effective no matter what challenges are presented by packaging, storage, and distribution requirements.

Many medicines have a stringent stability profile, where the acceptable temperature range in which the drug must be stored and distributed is strictly dictated to ensure the product remains safe and effective. This is becoming the norm rather than the exception, with large molecules and biologic medicines now playing a more prominent role in clinical development. Therefore, ensuring the biologics are optimally safe and effective is often an issue of sustaining the product at very specific temperatures and maintaining these requisites despite what can be differing, and even extreme, environmental conditions.

To control the temperature conditions of the drug at every step in the supply chain, it is critical that trial sponsors consider a range of factors. From the point in time that the drug is first manufactured through to the end delivery to the patient, it will be exposed to a multitude of environments during its lifecycle. Stages of this will include initial packaging, storage at the distribution facility, clinical site transportation and storage, and distribution to the patient.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Brian Keesee, Vice President and General Manager of PCI’s Global Clinical Operations and Supply, has spent his entire career in the pharma industry. In his current role, Brian is responsible for global clinical operations and project management, including PCI’s stateof- the-art packaging and distribution facilities located in Rockford, US, and Bridgend, UK.
spacer
Brian Keesee
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Signant Health Joins the Association of Clinical Research Organizations (ACRO) to Add a Technology Perspective to Conversations with Legislators and Industry Leaders about the Future of Clinical Research

PHILADELPHIA, PA – November 21, 2019: Signant Health announced today that it has joined the non-profit Association of Clinical Research Organizations (ACRO). ACRO, a global coalition of research and technology companies, makes it their mission to advocate as the collective voice of the innovative clinical research industry to regulators and policymakers, educating stakeholders and shaping policies that foster efficient, effective and safe conduct of clinical research.
More info >>

White Papers

Autoinjector testing made safe efficient and flexible

ZwickRoell

The autoinjector market is one of the fastest growing markets across almost all pharmaceutical applications. Studies expect a global market volume of approximately USD 2.5 billion by 2020, with pre-filled autoinjectors representing the largest market segment. There are a variety of tests that can be performed on autoinjectors, and these are well-demonstrated by the Zwick product portfolio. The Ulm-based company and specialist in testing systems offers a variety of testing systems that are already being successfully used by multiple pharmaceutical companies.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement